# Triamcinolone Acetonide Injection: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: resolved
- Source statuses: Resolved
- FDA package records: 1
- Latest FDA row update: 07/31/2026
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- Harrow Eye, LLC — Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01) — FDA availability: Not stated — updated: 07/31/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/triamcinolone-acetonide-injection)
- [JSON record](https://citefacts.com/shortages/triamcinolone-acetonide-injection.json)